Evidence map›Paper›PMID 34238134›Full record

ArticleHealth marketing quarterly

Consumers' experience with and attitudes toward direct-to-consumer prescription drug promotion: a nationally representative survey.

Kathryn J Aikin, Helen W Sullivan, Jennifer Berktold, Karen L Stein, Victoria J Hoverman

Open access · greenAbstract read
In one paragraph

Article in Health marketing quarterly. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kathryn J AikinOffice of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, Maryland, USA.
Helen W SullivanOffice of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, Maryland, USA.
Jennifer BerktoldSocial Policy & Economics, Westat, Inc, Rockville, Maryland, USA.
Karen L SteinSocial Policy & Economics, Westat, Inc, Rockville, Maryland, USA.
Victoria J HovermanSocial Policy & Economics, Westat, Inc, Rockville, Maryland, USA.
Westat (United States) · USUnited States Food and Drug Administration · US

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

The way consumers get and seek health information reflects the current information landscape. To gather updated insights on consumer experiences with and attitudes towards direct-to-consumer (DTC) promotion of prescription drugs, we conducted a nationally representative survey of 1,744 US adults using a mail-push-to-web methodology with paper nonresponse follow-up. Results showed high exposure and indifferent attitudes to DTC promotion. Respondents reported DTC promotion has prompted action, particularly searches for more information, increased use of online resources, and some reported that they refused to take or stopped taking a prescription drug because they saw or heard about the drug's side effects.

Indexed as

Drug-Related Side Effects and Adverse ReactionsPrescription DrugsAdultAdvertisingAttitudeHumansSurveys and QuestionnairesPrescription DrugsadvertisingattitudesbehaviorDirect-to-consumerexposureprescription drugs

Identifiers

PMID34238134
PMCPMC8815450
OpenAlexW3178381028

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.